VCIM
ATRS

Velan Capital Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History

Velan Capital Investment Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,346,971
Closed -$5.52M – 30
2022
Q1 		$5.52M Buy
+1,346,971
New +$4.89M 5.13% 7

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Velan Capital Investment Management's ATRS Position: Q2 2022 in Review

Velan Capital Investment Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,346,971 shares — an estimated $5.52M sold.

Velan Capital Investment Management first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $5.52M in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Velan Capital Investment Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Velan Capital Investment Management sold 1,346,971 Antares Pharma, Inc. shares in Q2 2022, an estimated $5.52M.
  • Velan Capital Investment Management first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
  • Velan Capital Investment Management's Antares Pharma, Inc. position peaked at $5.52M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Velan Capital Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.